Patent & IP news for September 4, 2010

Bone Loss from www.patenthawk.com

Eli Lilly got 6,458,811 and 6,894,064 (the "Particle Size Patents") for processing "raloxifene particles until their size falls 'within a specified narrow range.'" Raloxifene, an antiestrogen, aims at treating osteoporosis in ...

Share via E–mail | Twitter | Facebook

Innovation- It's All In The Mind from spicyipindia.blogspot.com

There’s this series of videos of Harvard Business Publishing on YouTube I came across recently, a good number of which are dedicated to the theme of innovation. One of them, which I found to ...

Share via E–mail | Twitter | Facebook

Licensing Executives Society Annual Meeting: Sept. 26-29 from ipspotlight.com

The following information is reproduced from a press release issued by the Licensing Executives Society:

WASHINGTON, August 25, 2010–Over one thousand of the world’s leading intellectual property (IP), licensing and business development professionals ...

Share via E–mail | Twitter | Facebook

IP finance from ipfinance.blogspot.com

When you practice in a hi-tech epicentre, such as I do, you cannot help but follow the every move of the venture capital industry. For that reason, the caption of an article that appeared in ...

Share via E–mail | Twitter | Facebook

Microsoft Files Another Reexam Against $290 Million i4i Patent from ipwatchdog.com

I don’t know why Microsoft didn’t present all the prior art in the Texas case sooner, and I can't explain why they might have wanted to wait until after asking the Supreme ...

Share via E–mail | Twitter | Facebook